Nova Mentis Life Science Corp.

CNQ:NOVA.CN

$0.005 CAD

-$0.01 (-50.0%)

Volume
0
Average Volume
55.76K
Market Capitalization
$148.32K
P/E Ratio
-1.18
Dividend Yield
0.00%
Price Target
$
Year High
$0.03
Year Low
$0.01
Payout Ratio
$0.00
Current Ratio
$0.02

Industry, Sector & symbol

Stock Exchange Canadian Securities Exchange
CEO Mr. Steve Loutskou
Industry Biotechnology
Sector Healthcare
Current Symbol NOVA.CN
CUSIP None
CIK None
Web https://www.novamentis.ca
Phone 778-819-0244
Currency CAD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio -0.06
Payout Ratio 0.00
Current Ratio 0.02
Quick Ratio 0.02
Cash Ratio 0.01

Sales & Book Value

Annual Sales $28346
Price / Sales 0.00
Cash Flow 0.00
Price / Cash Flow -2.27
Price / Book -0.71

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0083
Trailing P/E Ratio -1.18
PEG Ratio -0.05
P/E Growth -0.05
Net Income $-1.22M
Net Margin 0.00%
Pretax Margin 0.00%
Return on Equity 73.69%
Return on Assets -2385.69%

Financials Score

AltmanZ Score -3290.37
Piotroski Score 1.00
Working Capital -1.06M
Total Assets 26.35K
Ebit -635.21K
Market Cap 148.32K
Total Liabilities 1.07M

Poll Results

About Nova Mentis Life Science Corp. (CNQ:NOVA.CN) Stock

Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. It is also involved in the research and development of anti-inflammatory effects of psilocybin for metabolic indications, such as obesity and diabetes; and development of cannabis products. Nova Mentis Life Science Corp. has a research agreement with the University of Central Florida (UCF) to develop a saliva serotonin assay. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. ...

Frequently Asked Questions

What is the current Nova Mentis Life Science Corp. (NOVA.CN) stock price?

Nova Mentis Life Science Corp.(CNQ:NOVA.CN) stock price is $0.005 in the last trading session. During the trading session, NOVA.CN stock reached the peak price of $0.03 while $0.0 was the lowest point it dropped to. The percentage change in NOVA.CN stock occurred in the recent session was --50.0% while the dollar amount for the price change in NOVA.CN stock was -$-0.01.

NOVA.CN's industry and sector of operation?

The CNQ listed NOVA.CN is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of NOVA.CN?

Mr. Steve Loutskou | President, Chief Executive Officer & Director
Mr. Derek Lloyd Harry Ivany | Executive Chairman
Ms. Rebecca Lynn Hudson C.A., CPA | Chief Financial Officer
Dr. Aylia Mohammadi B.Sc., M.Sc., Ph.D. | President & Chief Scientific Officer of Nova Mentis Biotech Corporation
Ms. Kelly Pladson | Corporate Secretary

How many employees does NOVA.CN have?

Number of NOVA.CN employees currently stands at None. NOVA.CN operates from 700-838 West Hasting Street, Vancouver, BC V6C 0A6, CA.

Link for NOVA.CN official website?

Official Website of NOVA.CN is: https://www.novamentis.ca

How do I contact NOVA.CN?

NOVA.CN could be contacted at phone #778-819-0244 and can also be accessed through its website. NOVA.CN operates from 700-838 West Hasting Street, Vancouver, BC V6C 0A6, CA.

How many shares of NOVA.CN are traded daily?

The average number of NOVA.CN shares traded daily for last 3 months was 55.76K.

What is the market cap of NOVA.CN currently?

The market value of NOVA.CN currently stands at $148.32K with its latest stock price at $0.005